Business

EcoFlow Launches DELTA 3 Plus and RIVER 3 Plus in Australia

SYDNEY,Feb. 17,2025--EcoFlowis introducing two new portable power solutions,designed to give Australians flexible,innovative and reliable energy for every situation. The EcoFlow DELTA 3 Plus is a depe

02-18 EcoFlow Australia

Voithru Wraps Up 2nd t ōtus Translation Contest with Great Success

Record-Breaking 3,586 Translators Participated in tōtus Translation Contest SEOUL,South Korea,Feb. 17,2025-- On February 8,2025,VOITHRU,a leader in cultural content translation,successfully concluded

02-18 Voithru

Minish Holds First Seminar in Japan with Great Success - Over 100 Dentists in Attendance

"Impressed by Extensive Full-Mouth Rehabilitation Cases","Anti-Aging Effects Highly Praised"

02-18 Minish Technology Inc.

Reolink Makes Wireless Security Camera Systems Accessible to All Homes

LOS ANGELES,Feb. 17,2025-- Every homeowner deserves peace of mind when it comes to home security. Reolink,an innovative leader in intelligent visual technology for the home,brings the Wireless Securi

02-18 Reolink Innovation Inc.

Duke and Duke-NUS forge new frontiers in climate health research with S$1million funding

The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration

02-17

ATxEnterprise 2025 Celebrates Five Years of Powering Enterprise Technology, Cybersecurity, and Digital Transformation

SINGAPORE,Feb. 14,2025-- ATxEnterprise (ATxE) 2025,a flagship event of Asia Tech x Singapore (ATxSG),returns for its fifth year,providing a strategic platform for enterprises,governments,and technolo

02-17 Informa Festivals

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 14th + KARMAN POPS DOUBLE DIGIT IPO

NEW YORK,Feb. 14,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insight

02-17 New York Stock Exchange

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi

02-14

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w

02-14

Year of the Snake Celebrations Bring Lively Festivities to Cangzhou

CANGZHOU,China,Feb. 13,2025-- A news report from xinhuanet: The Year of the Snake ushers in an energetic Spring Festival in Cangzhou,Hebei Province. Locals and tourists alike are reveling in the festi

02-14